San Diego, CA, United States of America

Venkata Ramana Doppalapudi

This inventor holds 45 USPTO granted patents and 36 published patent applications, plus 1 CIPO patent and 2 EPO patents, primarily in Muscle Dystrophy Treatments. Top assignees: Avidity Biosciences, Inc., Covx Technology Ireland, Ltd., Celmed Oncology (USA), Inc.. Active years: 2006-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Venkata Ramana Doppalapudi. Retrieved from https://idiyas.com/inventor/venkata-ramana-doppalapudi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 45 

% Patents Active = 84.4

 

 

Average Co-Inventor Count = 5.7

ph-index = 13

Forward Citations = 389(Granted Patents)


Location History:

  • San Diego, CA (US) (2006 - 2024)
  • La Jolla, CA (US) (2023 - 2024)

Company Filing History:


Years Active: 2006-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Muscle Dystrophy
Exon Skipping
Nucleic Acid-Polypeptide
Anti-Transferrin Receptor
Myotonic Dystrophy
Anti-Angiogenic Compounds
Muscle Atrophy
Therapeutic Compositions
45 patents (USPTO):Explore Patents

As an AI assistant specialized in innovations, inventions, inventors, patent attorneys, assignees and patents, I can provide you with an article about inventor Venkata Ramana Doppalapudi.

Title: The Innovations of Inventor Venkata Ramana Doppalapudi

Introduction:

Venkata Ramana Doppalapudi is a prolific inventor based in San Diego, CA (US), with an impressive track record of 32 patents to his name. His groundbreaking contributions in the field of pharmaceuticals and biotechnology have garnered significant attention in the industry.

Latest Patents:

Venkata Ramana Doppalapudi's recent patents include:

1. "Compositions and Methods of Treating Muscle Atrophy and Myotonic Dystrophy" - This patent discloses polynucleic acid molecules, pharmaceutical compositions, and methods for treating muscle atrophy or myotonic dystrophy.

2. "Anti-Transferrin Receptor Antibodies and Uses Thereof" - This patent focuses on anti-transferrin receptor antibodies, conjugates, and pharmaceutical compositions for delivering a payload and treating conditions using these antibodies.

Career Highlights:

Venkata Ramana Doppalapudi has made significant contributions to companies such as Avidity Biosciences, Inc. and CovX Technology Ireland, Ltd. His expertise and innovative spirit have driven advancements in the biotech industry, earning him recognition as a leading figure in the field.

Collaborations:

Throughout his career, Venkata Ramana Doppalapudi has collaborated with renowned professionals in the industry, including Michael Caramian Cochran and Rob Burke. These partnerships have resulted in the development of groundbreaking technologies and therapies that have the potential to revolutionize the field of biotechnology.

Conclusion:

Venkata Ramana Doppalapudi's relentless pursuit of innovation and his groundbreaking contributions in the field of biotechnology have cemented his reputation as a visionary inventor. His patents and collaborations stand as a testament to his dedication to advancing science and improving the lives of individuals around the world.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…